JP2001524958A - 新規な液晶をベースとする生物接着性薬剤送出系 - Google Patents

新規な液晶をベースとする生物接着性薬剤送出系

Info

Publication number
JP2001524958A
JP2001524958A JP54475798A JP54475798A JP2001524958A JP 2001524958 A JP2001524958 A JP 2001524958A JP 54475798 A JP54475798 A JP 54475798A JP 54475798 A JP54475798 A JP 54475798A JP 2001524958 A JP2001524958 A JP 2001524958A
Authority
JP
Japan
Prior art keywords
composition
weight
liquid crystal
crystal phase
succinate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
JP54475798A
Other languages
English (en)
Japanese (ja)
Inventor
シルベスト ニールセン，リーセ
Original Assignee
ジーエス ディベロップメント アクティエボラーグ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ジーエス ディベロップメント アクティエボラーグ filed Critical ジーエス ディベロップメント アクティエボラーグ
Publication of JP2001524958A publication Critical patent/JP2001524958A/ja
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1274—Non-vesicle bilayer structures, e.g. liquid crystals, tubules, cubic phases, cochleates; Sponge phases

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
JP54475798A 1997-04-17 1998-04-17 新規な液晶をベースとする生物接着性薬剤送出系 Ceased JP2001524958A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DK43597 1997-04-17
DK0435/97 1997-04-17
PCT/DK1998/000159 WO1998047487A1 (en) 1997-04-17 1998-04-17 A novel bioadhesive drug delivery system based on liquid crystals

Publications (1)

Publication Number Publication Date
JP2001524958A true JP2001524958A (ja) 2001-12-04

Family

ID=8093507

Family Applications (1)

Application Number Title Priority Date Filing Date
JP54475798A Ceased JP2001524958A (ja) 1997-04-17 1998-04-17 新規な液晶をベースとする生物接着性薬剤送出系

Country Status (5)

Country Link
EP (1) EP0975331A1 (de)
JP (1) JP2001524958A (de)
AU (1) AU6919598A (de)
CA (1) CA2286052A1 (de)
WO (1) WO1998047487A1 (de)

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005532366A (ja) * 2002-06-13 2005-10-27 リオトロピック セラピュティックス アイエヌシー． 非パラフィン系疎水性物による逆液晶相
WO2006118246A1 (ja) * 2005-04-28 2006-11-09 Japan Science And Technology Agency 経皮吸収促進剤
JP2008526932A (ja) * 2005-01-14 2008-07-24 カムルス エービー 局所用生体付着性製剤
JP2008528463A (ja) * 2005-01-21 2008-07-31 カムルス エービー 医薬脂質組成物
JP2009500399A (ja) * 2005-07-08 2009-01-08 エル・ジー ハウスホールド アンド ヘルスケア リミティッド 相転移の口臭除去剤
JP2012214494A (ja) * 2005-01-14 2012-11-08 Camurus Ab 局所用生体付着性製剤
WO2013115201A1 (ja) * 2012-01-31 2013-08-08 参天製薬株式会社 非水性液体組成物
JP2014159403A (ja) * 2013-01-25 2014-09-04 Rohto Pharmaceut Co Ltd 外用組成物
JP2022536234A (ja) * 2019-10-31 2022-08-15 ケミストリーアールエックス． ピリミジン誘導体含有組成物

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20010003580A1 (en) * 1998-01-14 2001-06-14 Poh K. Hui Preparation of a lipid blend and a phospholipid suspension containing the lipid blend
CA2378401A1 (en) * 1999-08-06 2001-02-15 Max-Delbruck-Centrum Fur Molekulare Medizin Implantable active ingredient depot
US6465002B1 (en) 2000-03-13 2002-10-15 Brown University Research Foundation Liquid crystalline polymers
US20020153508A1 (en) 2000-06-29 2002-10-24 Lynch Matthew Lawrence Cubic liquid crystalline compositions and methods for their preparation
DE10057770A1 (de) * 2000-11-22 2002-05-23 Beiersdorf Ag Hautpflegeprodukte mit einem Gehalt an dispersen Flüssigkristallen, welche kubische Phasen darstellen ,
DE10057767A1 (de) * 2000-11-22 2002-05-23 Beiersdorf Ag Deodorant- und Antitranspirantprodukte mit einem Gehalt an dispersen Flüssigkristallen, welche kubische Phasen darstellen
US6936187B2 (en) 2001-02-21 2005-08-30 Matthew Lawrence Lynch Functionalized cubic liquid crystalline phase materials and methods for their preparation and use
US6656385B2 (en) 2001-02-21 2003-12-02 The Procter & Gamble Company Functionalized cubic liquid crystalline phase materials and methods for their preparation and use
KR100533460B1 (ko) * 2002-07-20 2005-12-08 대화제약 주식회사 난용성 약물의 가용화용 점막흡착성 조성물, 이를 이용한난용성 약물의 가용화용 제형 및 이들의 제조 방법
US7731947B2 (en) 2003-11-17 2010-06-08 Intarcia Therapeutics, Inc. Composition and dosage form comprising an interferon particle formulation and suspending vehicle
JP2007504256A (ja) * 2003-09-01 2007-03-01 メイン・ファ−マ・インタ−ナショナル・プロプライエタリ−・リミテッド 生物活性剤の送達のための組成物及び方法
AU2005324794C1 (en) * 2003-11-07 2010-12-02 Camurus Ab Somatostatin analogue formulations
US8871712B2 (en) 2005-01-14 2014-10-28 Camurus Ab Somatostatin analogue formulations
US9649382B2 (en) 2005-01-14 2017-05-16 Camurus Ab Topical bioadhesive formulations
GB0501364D0 (en) * 2005-01-21 2005-03-02 Camurus Ab Compositions
WO2006083761A2 (en) 2005-02-03 2006-08-10 Alza Corporation Solvent/polymer solutions as suspension vehicles
US11246913B2 (en) 2005-02-03 2022-02-15 Intarcia Therapeutics, Inc. Suspension formulation comprising an insulinotropic peptide
CN101217940B (zh) 2005-06-06 2013-03-27 卡穆鲁斯公司 Glp-1类似物制剂
JP5143131B2 (ja) 2006-05-30 2013-02-13 インターシア セラピューティクス，インコーポレイティド 浸透圧送出システムの二片構成内部チャネル型の流れモジュレータ
PL2359808T3 (pl) 2006-08-09 2013-10-31 Intarcia Therapeutics Inc Osmotyczne systemy dostawcze i zespoły tłokowe
CA2683610C (en) 2007-04-23 2013-01-08 Intarcia Therapeutics, Inc. Suspension formulations of insulinotropic peptides and uses thereof
GB0711656D0 (en) 2007-06-15 2007-07-25 Camurus Ab Formulations
GB0716385D0 (en) 2007-08-22 2007-10-03 Camurus Ab Formulations
DK2240155T3 (da) 2008-02-13 2012-09-17 Intarcia Therapeutics Inc Indretninger, formuleringer og fremgangsmåder til levering af flere gavnlige midler
GB0815435D0 (en) 2008-08-22 2008-10-01 Camurus Ab Formulations
EP2498754B1 (de) * 2009-06-25 2018-06-06 Yissum Research Development Company of the Hebrew University of Jerusalem, Ltd. Reverse hexagonale mesophasen (h ii) und ihre verwendung
KR101823699B1 (ko) 2009-09-28 2018-01-30 인타르시아 세라퓨틱스 인코포레이티드 실질 항정상태 약물 전달의 신속 확립 및/또는 종결
US20120208755A1 (en) 2011-02-16 2012-08-16 Intarcia Therapeutics, Inc. Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers
KR101494594B1 (ko) 2011-08-30 2015-02-23 주식회사 종근당 약리학적 활성물질의 서방성 지질 초기제제 및 이를 포함하는 약제학적 조성물
CA2874367C (en) 2012-05-25 2020-08-18 Camurus Ab Somatostatin receptor agonist formulations
KR101586791B1 (ko) * 2012-12-28 2016-01-19 주식회사 종근당 ＧｎＲＨ 유도체의 서방성 지질 초기제제 및 이를 포함하는 약제학적 조성물
KR101601035B1 (ko) 2013-02-28 2016-03-08 주식회사 종근당 키토산 및 액상결정 형성 물질을 포함하는 유전자 전달용 조성물
US10105358B2 (en) * 2013-05-09 2018-10-23 Zeenar Enterprises Pty Ltd Niacin formulation
US9889085B1 (en) 2014-09-30 2018-02-13 Intarcia Therapeutics, Inc. Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c
WO2016195338A2 (ko) * 2015-05-29 2016-12-08 서울대학교산학협력단 액정 나노 입자, 이의 제조방법 및 친유성 약물이 봉입된 액정 나노입자를 함유하는 약물 전달 시스템
MX2017015504A (es) 2015-06-03 2018-05-15 Intarcia Therapeutics Inc Sistemas de colocacion y remoción de implante.
AU2017268161B2 (en) 2016-05-16 2020-03-12 Intarcia Therapeutics, Inc. Glucagon-receptor selective polypeptides and methods of use thereof
USD840030S1 (en) 2016-06-02 2019-02-05 Intarcia Therapeutics, Inc. Implant placement guide
USD860451S1 (en) 2016-06-02 2019-09-17 Intarcia Therapeutics, Inc. Implant removal tool
AU2018206539A1 (en) 2017-01-03 2019-07-18 Intarcia Therapeutics, Inc. Methods comprising continuous administration of a GLP-1 receptor agonist and co-administration of a drug
CN114632059A (zh) * 2020-12-15 2022-06-17 南京海辰药业股份有限公司 一种包含瑞德西韦的静脉输注液体制剂及制备方法
CN112791047A (zh) * 2021-01-15 2021-05-14 中国人民解放军总医院第三医学中心 一种白藜芦醇层状液晶及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5262164A (en) * 1989-11-17 1993-11-16 The Procter & Gamble Company Sustained release compositions for treating periodontal disease
SE9200952D0 (sv) * 1992-03-27 1992-03-27 Kabi Pharmacia Ab Pharmaceutical carrier system containing defined lipids
GB9409778D0 (en) * 1994-05-16 1994-07-06 Dumex Ltd As Compositions
SE518578C2 (sv) * 1994-06-15 2002-10-29 Gs Dev Ab Lipidbaserad komposition
WO1997013528A1 (en) * 1995-10-12 1997-04-17 Gs Development Ab A pharmaceutical composition for administration of an active substance to or through a skin or mucosal surface

Cited By (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005532366A (ja) * 2002-06-13 2005-10-27 リオトロピック セラピュティックス アイエヌシー． 非パラフィン系疎水性物による逆液晶相
JP2008526932A (ja) * 2005-01-14 2008-07-24 カムルス エービー 局所用生体付着性製剤
JP2008526934A (ja) * 2005-01-14 2008-07-24 カムルス エービー ＧｎＲＨ類似体製剤
JP2012214494A (ja) * 2005-01-14 2012-11-08 Camurus Ab 局所用生体付着性製剤
JP2008528463A (ja) * 2005-01-21 2008-07-31 カムルス エービー 医薬脂質組成物
US9095560B2 (en) 2005-04-28 2015-08-04 Japan Science And Technology Agency Method of enhancing transdermal absorption using a composition comprising POE octyl dodecyl ether and squalane
WO2006118246A1 (ja) * 2005-04-28 2006-11-09 Japan Science And Technology Agency 経皮吸収促進剤
JPWO2006118246A1 (ja) * 2005-04-28 2008-12-18 独立行政法人科学技術振興機構 経皮吸収促進剤
JP2009500399A (ja) * 2005-07-08 2009-01-08 エル・ジー ハウスホールド アンド ヘルスケア リミティッド 相転移の口臭除去剤
WO2013115201A1 (ja) * 2012-01-31 2013-08-08 参天製薬株式会社 非水性液体組成物
JP2014159403A (ja) * 2013-01-25 2014-09-04 Rohto Pharmaceut Co Ltd 外用組成物
JP2018065884A (ja) * 2013-01-25 2018-04-26 ロート製薬株式会社 外用組成物
JP2022536234A (ja) * 2019-10-31 2022-08-15 ケミストリーアールエックス． ピリミジン誘導体含有組成物

Also Published As

Publication number Publication date
AU6919598A (en) 1998-11-13
EP0975331A1 (de) 2000-02-02
CA2286052A1 (en) 1998-10-29
WO1998047487A1 (en) 1998-10-29

Similar Documents

Publication Publication Date Title
JP2001524958A (ja) 新規な液晶をベースとする生物接着性薬剤送出系
AU702030B2 (en) A pharmaceutical composition for administration of an active substance to or through a skin or mucosal surface
US6228383B1 (en) Use of fatty acid esters as bioadhesive substances
EP0752855B1 (de) Verwendung von fettsäureester als bioklebstoffe
EP2301525B1 (de) Topische Ibuprofen-Formulierung
JP3903061B2 (ja) 薬物を含有するナノ粒子およびその製造方法、ならびに当該ナノ粒子からなる非経口投与用製剤
JP3240330B2 (ja) コラン酸の塩を含有する医薬調合剤および化粧品調合剤
EP1888033B1 (de) Verfahren und zusammensetzung zur behandlung von entzündlichen erkrankungen
TW200534863A (en) Composition and dosage form comprising an amphiphilic molecule as a suspension vehicle
MXPA02004930A (es) Composiciones estroprogestativos topicos con efecto sistemico.
JP5843416B2 (ja) ステロイドホルモンを含むタブレット
JP2002537317A (ja) 疎水性治療剤の改善された送達のための組成物および方法
RU2560677C2 (ru) Кожная композиция, включающая аналог витамина d и смесь растворителя и поверхностно-активных веществ
JP2023139134A (ja) 皮膚疾患を治療するためのフェノルドパム局所製剤
CZ2004778A3 (cs) Farmaceutická formule zahrnující cyklosporin a její použití
JP2646025B2 (ja) コルチコステロイド含有ローション剤
JPH11504313A (ja) 新規な医薬組成物
JP2003342171A (ja) ディスラノール投与のための組成物
JPH11509515A (ja) 新規な医薬処方
JP3689137B2 (ja) アレルギー性皮膚疾患治療用外用剤
JP2848529B2 (ja) 外用剤
EP1366758A1 (de) Neue ophthalmische zusammensetzungen
JPS62132828A (ja) 循環器系疾患治療用皮膚外用剤
JPH08301759A (ja) マロチラートのリンパ指向性製剤
IL150334A (en) A system for administering drugs through the skin

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20050412

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20081209

A313 Final decision of rejection without a dissenting response from the applicant

Free format text: JAPANESE INTERMEDIATE CODE: A313

Effective date: 20090420

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20090602